AR
Aparna Rachamallu
About Aparna Rachamallu
Data last updated:
Aparna Rachamallu is a Director at Ur Advanced Therapeutics Private Limited (since 2023), Director at Amigos Molecular Solutions Private Limited (since 2024) and Director at Ur Revnostics Private Limited (since 2022). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹1.08 Cr; the largest is Ur Advanced Therapeutics Private Limited at ₹56.9 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ur Advanced Therapeutics Private Limited U73100TG2020PTC141847 | Director | 16 Mar 2023 | 2020 | ₹56.9 Lakh (FY 2025) | Active |
 Amigos Molecular Solutions Private Limited U74999AP2019PTC110178 | Director | 30 Sep 2024 | 2019 | ₹50.9 Lakh (FY 2025) | Active |
 Ur Revnostics Private Limited U73100TG2022PTC160132 | Director | 25 Feb 2022 | 2022 | Active |
Board colleagues of Aparna Rachamallu
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bhanu Prasad Kommineni | 01408377 | Ur Advanced Therapeutics Private Limited | Director |
| Jangamreddy Jagan Mohan Reddy | 08797859 | Ur Advanced Therapeutics Private Limited , Ur Revnostics Private Limited | Director |
| Sai Pooja Anne | 10402017 | Ur Advanced Therapeutics Private Limited | Director |
| Mallu Venkata Siva Prasad Reddy | 06638104 | Amigos Molecular Solutions Private Limited | Director |
| Nandaluri Venkata Narayana Reddy | 07203534 | Amigos Molecular Solutions Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Aparna Rachamallu
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aparna Rachamallu
Aparna Rachamallu currently holds 3 directorships: Ur Advanced Therapeutics Private Limited (Director, since 16 Mar 2023, revenue ₹56.9 Lakh (FY 2025)); Amigos Molecular Solutions Private Limited (Director, since 30 Sep 2024, revenue ₹50.9 Lakh (FY 2025)); Ur Revnostics Private Limited (Director, since 25 Feb 2022).
Aparna Rachamallu was first appointed on 25 Feb 2022 as Director at Ur Revnostics Private Limited. The most recent appointment on record is 30 Sep 2024 at Amigos Molecular Solutions Private Limited.
The 2 current companies of Aparna Rachamallu that report revenue have a combined latest revenue of ₹1.08 Cr: Ur Advanced Therapeutics Private Limited ₹56.9 Lakh (FY 2025); Amigos Molecular Solutions Private Limited ₹50.9 Lakh (FY 2025).
The current boards of Aparna Rachamallu's companies include Bhanu Prasad Kommineni (Ur Advanced Therapeutics Private Limited), Jangamreddy Jagan Mohan Reddy (Ur Advanced Therapeutics Private Limited), Sai Pooja Anne (Ur Advanced Therapeutics Private Limited), Mallu Venkata Siva Prasad Reddy (Amigos Molecular Solutions Private Limited), Nandaluri Venkata Narayana Reddy (Amigos Molecular Solutions Private Limited).